drugset / Trial / NCT04163835

The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats

NCT04163835 ↗

Phase 4 Unknown 150 enrolled China Academy of Chinese Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

A Randomized, double-blind, placebo-controlled, four dose groups, post-marketing clinical trial, to evaluate the efficacy and safety of Wenxin granules in treating atrial premature beats by different doses,to provide a scientific basis for rational clinical use of drug.

Timeline

Start
2015-09-01
Primary completion
2022-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Wenxin Granules Traditional medicine (herbal / TCM) 2.5 g Oral
Subject Wenxin Granules Traditional medicine (herbal / TCM) 5 g Oral
Subject Wenxin Granules Traditional medicine (herbal / TCM) 10 g Oral